Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Accelerated rTMS for Post-Stroke Apathy

NCT: NCT05878457 · COMPLETED

NCT IDNCT05878457
StatusCOMPLETED
Start Date2023-12-01
Completion2025-04-30
SponsorMedical University of South Carolina (OTHER)
First posted
Last updated

Brief Summary

This pilot study will investigate the safety, feasibility, tolerability, and preliminary efficacy of accelerated high-dose repetitive transcranial magnetic stimulation (rTMS) targeting the medial prefrontal cortex (mPFC) to address apathy symptoms in individuals with chronic stroke.

Frequently Asked Questions

What is Accelerated rTMS for Post-Stroke Apathy?

Accelerated rTMS for Post-Stroke Apathy is a clinical trial registered under NCT05878457. Current status: COMPLETED.

What is the status of NCT05878457?

The current status of NCT05878457 (Accelerated rTMS for Post-Stroke Apathy) is: COMPLETED.

When did Accelerated rTMS for Post-Stroke Apathy start?

Accelerated rTMS for Post-Stroke Apathy started on 2023-12-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.